SKY-0515 clinical trials

Study to Evaluate the Pharmacodynamics, Safety and Efficacy of SKY-0515 in Participants With Huntington's Disease

This study is testing a new oral drug, SKY-0515, for Huntington's disease. Researchers want to see if it can reduce harmful proteins in the brain and improve symptoms. It's for adults aged 25 and over with a confirmed diagnosis of Huntington's.